| MeSH term | MeSH ID | Detail |
|---|---|---|
| Cleidocranial Dysplasia | D002973 | 1 associated lipids |
| Prediabetic State | D011236 | 1 associated lipids |
| Rheumatic Fever | D012213 | 1 associated lipids |
| Chronic Periodontitis | D055113 | 1 associated lipids |
| Intracranial Hemorrhage, Traumatic | D020198 | 1 associated lipids |
| Neoplastic Syndromes, Hereditary | D009386 | 1 associated lipids |
| Scleroderma, Limited | D045745 | 1 associated lipids |
| Vestibulocochlear Nerve Diseases | D000160 | 1 associated lipids |
| Dental Pulp Exposure | D003789 | 1 associated lipids |
| Dental Occlusion, Traumatic | D003769 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jung YJ et al. | Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. | 2017 | Mol Oral Microbiol | pmid:27484636 |
| Kuroyanagi G et al. | (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. | 2017 | Prostaglandins Other Lipid Mediat. | pmid:28163121 |
| Chen X et al. | Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. | 2017 | Environ. Toxicol. Pharmacol. | pmid:28738286 |
| Shetelig C et al. | Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. | 2017 | PLoS ONE | pmid:28253327 |
| Irtyuga O et al. | NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. | 2017 | Biomed Res Int | pmid:28246602 |
| Hanmoto T et al. | Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. | 2017 | Biomed. Res. | pmid:28239034 |
| Fioramonti M et al. | Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. | 2017 | Oncotarget | pmid:28223547 |
| Xiong L et al. | Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. | 2017 | J. Cell Biol. | pmid:28193701 |
| Fortner RT et al. | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. | 2017 | BMC Med | pmid:28173834 |
| Chung ST et al. | Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. | 2017 | Mol. Cancer | pmid:28143606 |